Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
EDP-305 is a novel oral FXR agonist under development for the treatment of MASH
Emerging evidence suggests it can accelerate regrowth in chronic or stubborn TE
It's like applying a protective, anti-rust coating to your cellular machinery, allowing it to function more efficiently and last longer
The largest oral trial already showed that a longer study did not guarantee a better result
The full bundle amount is charged at checkout before a provider has reviewed your case or confirmed your eligibility
In the meantime, NICE-approved weight management options are available for eligible patients in the UK
US$ 29.52
US$ 20.20
US$ 20.61
US$ 23.57
US$ 24.50
US$ 28.68
US$ 27.79
